Skip to main content
. 2024 Jun 19;10(13):e33114. doi: 10.1016/j.heliyon.2024.e33114

Fig. 1.

Fig. 1

Activity of ceftolozane-tazobactam. A summary figure showing susceptibility rates of different bacterial groups to ceftolozane-tazobactam, along with Enterobacterales that may produce extended-spectrum-β-lactamase (ESBL) or AmpC β-lactamase; as well as Pseudomonas aeruginosa, all of which were collected from Taiwan (2012–2021) [8,[10], [11], [12], [13], [14], [15], [16]].